Some studies showed that AML patients with higher XIAP protein expression underwent a markedly shorter survival and duration of remission and harboured intermediate or poor cytogenetics compared to patients with lower XIAP protein levels.33, 34, 35. The gene discussed is XIAP; the disease is acute myeloid leukemia.